PT
Pelthos Therapeutics Inc. (PTHS)
AMEX·Healthcare·Biotechnology
$28.50
+7.55%
Mkt Cap $15.45M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$60.50
Range $55.00 – $66.00
Implied Upside
+112.3%
Consensus $60.50 vs current $28.50
AMEX·Healthcare·Biotechnology
$28.50
+7.55%
Mkt Cap $15.45M
No recent rating data.
Price Target (7 analysts)
$60.50
Range $55.00 – $66.00
+112.3%
Consensus $60.50 vs current $28.50